Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Lostchannel on Jan 20, 2021 10:46am

Watchlist

This morinings Globe & Mail in the "Upgrades & Downgrades section of the Globe Investor. 
Industrial Alliance analyst Chelsea Stellick put out a research report previewing Biotech stocks. She unveiled her "2021 Immediate Watch List" 
Stating the obvious - There are 5 stocks on the list and Antibe is one of those 5. 
Interesting - due to the traditional risk in biotech I think this is typical of analysts and the advisors. They are risk adverse for their clients so need more solid catalysts and news to jump in big. This is a good sign for the future to make her list.
Comment by Forestview on Jan 20, 2021 12:22pm
LC - Can you cut and paste the article in here?
Comment by YBTORONTO on Jan 20, 2021 9:17pm
https://www.theglobeandmail.com/investing/markets/inside-the-market/article-wednesdays-analyst-upgrades-and-downgrades-142/
Comment by Straylight on Jan 21, 2021 9:13am
Thanks, too bad its behind their paywall...
Comment by Forestview on Jan 21, 2021 9:43am
Here is the blurb.  It's not as great as I thought.  She only has it listed on her WATCH list.  No write up with it as to why.  But, I guess it's still positive news: In a research report previewing the year in the Healthcare and Biotechnology sector, Industrial Alliance Securities’ Chelsea Stellick made a pair of rating changes and unveiled her “2021 Immediate Watch ...more